MRNA (STOCKS)
Moderna, Inc. Common Stock
$63.650000
-0.020000 (-0.03%)
Prev close: $63.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stéphane Bancel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $29,337.82M
- Employees
- 5,800
- P/E (TTM)
- -7.97
- P/B (TTM)
- 3.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.23B |
| Benefits Costs and Expenses | $5.32B |
| Cost Of Revenue | $1.71B |
| Costs And Expenses | $5.55B |
| Gross Profit | $521.00M |
| Operating Expenses | $3.84B |
| Research and Development | $2.88B |
| Other Operating Expenses | $965.00M |
| Operating Income/Loss | -$3.32B |
| Income/Loss Before Equity Method Investments | -$3.09B |
| Income/Loss From Continuing Operations After Tax | -$3.15B |
| Income/Loss From Continuing Operations Before Tax | -$3.09B |
| Income/Loss From Equity Method Investments | -$2.00M |
| Income Tax Expense/Benefit | $64.00M |
| Net Income/Loss | -$3.15B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.15B |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.15B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.99 |
| Diluted Earnings Per Share | -$7.99 |
| Basic Average Shares | 1,184,000,000 |
| Diluted Average Shares | 1,184,000,000 |
| Assets | $10.96B |
| Current Assets | $5.82B |
| Inventory | $280.00M |
| Other Current Assets | $5.54B |
| Noncurrent Assets | $5.15B |
| Liabilities | $4.20B |
| Current Liabilities | $2.53B |
| Accounts Payable | $167.00M |
| Wages | $192.00M |
| Other Current Liabilities | $2.18B |
| Noncurrent Liabilities | $1.67B |
| Equity | $6.76B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.76B |
| Liabilities And Equity | $10.96B |
| Net Cash Flow From Operating Activities | -$1.07B |
| Net Cash Flow From Operating Activities, Continuing | -$1.07B |
| Net Cash Flow From Investing Activities | $905.00M |
| Net Cash Flow From Investing Activities, Continuing | $905.00M |
| Net Cash Flow From Financing Activities | $611.00M |
| Net Cash Flow From Financing Activities, Continuing | $611.00M |
| Net Cash Flow | $441.00M |
| Net Cash Flow, Continuing | $443.00M |
| Comprehensive Income/Loss | -$3.16B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.16B |
| Other Comprehensive Income/Loss | -$3.16B |
| Other Comprehensive Income/Loss Attributable To Parent | -$4.00M |